NSBT (Nano Silver Biotech Medical) Ltd.

NSBT specializes in antimicrobial wound care products, specifically hydrogel dressings. Their main focus is on preventing infection in wounds, whether they are chronic (long-term) or acute (short-term). The company’s flagship product, Silverband, uses silver-based technology to help reduce microbial contamination during the healing process.

NSBT is headquartered in the United States. The company’s location influences its regulatory compliance, particularly in how its devices are classified and authorized under U.S. medical device regulations.

NSBT’s products fall under the U.S. Food and Drug Administration’s (FDA) Class II (U) device classification. This classification is typically assigned to devices that pose moderate risk and require special controls to ensure safety and effectiveness, such as antimicrobial wound dressings.

Yes, NSBT’s devices are included in the FDA’s Unique Device Identifier (UDI) database. The UDI system helps track and identify medical devices throughout their lifecycle, ensuring transparency and traceability in the healthcare supply chain.